BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17314593)

  • 1. Prone mammoPET acquisition improves the ability to fuse MRI and PET breast scans.
    Moy L; Noz ME; Maguire GQ; Ponzo F; Deans AE; Murphy-Walcott AD; Kramer EL
    Clin Nucl Med; 2007 Mar; 32(3):194-8. PubMed ID: 17314593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets.
    Moy L; Ponzo F; Noz ME; Maguire GQ; Murphy-Walcott AD; Deans AE; Kitazono MT; Travascio L; Kramer EL
    J Nucl Med; 2007 Apr; 48(4):528-37. PubMed ID: 17401088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.
    Garcia-Velloso MJ; Ribelles MJ; Rodriguez M; Fernandez-Montero A; Sancho L; Prieto E; Santisteban M; Rodriguez-Spiteri N; Idoate MA; Martinez-Regueira F; Elizalde A; Pina LJ
    Eur Radiol; 2017 Aug; 27(8):3190-3198. PubMed ID: 28004161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fusion of prone FDG-PET and magnetic resonance imaging of the breasts in the evaluation of breast cancer.
    Moy L; Noz ME; Maguire GQ; Melsaether A; Deans AE; Murphy-Walcott AD; Ponzo F
    Breast J; 2010; 16(4):369-76. PubMed ID: 20443788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can 18F-FDG PET improve the evaluation of suspicious breast lesions on MRI?
    Bitencourt AG; Lima EN; Chojniak R; Marques EF; Souza JA; Andrade WP; Guimarães MD
    Eur J Radiol; 2014 Aug; 83(8):1381-6. PubMed ID: 24931922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementary abbreviated supine breast MRI following a standard prone breast MRI with single contrast administration: is it effective in detecting the initial contrast-enhancing lesions?
    Arıbal E; Buğdaycı O
    Diagn Interv Radiol; 2019 Jul; 25(4):265-269. PubMed ID: 31124788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast enhanced breast MRI: spatial displacement from prone to supine patient's position. Preliminary results.
    Carbonaro LA; Tannaphai P; Trimboli RM; Verardi N; Fedeli MP; Sardanelli F
    Eur J Radiol; 2012 Jun; 81(6):e771-4. PubMed ID: 22502792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Added value of prone position technique for PET-TAC in breast cancer patients].
    Vidal-Sicart S; Aukema TS; Vogel WV; Hoefnagel CA; Valdés-Olmos RA
    Rev Esp Med Nucl; 2010; 29(5):230-5. PubMed ID: 20624663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Magnetic Resonance Imaging and Computed Tomography for Breast Target Volume Delineation in Prone and Supine Positions.
    Pogson EM; Delaney GP; Ahern V; Boxer MM; Chan C; David S; Dimigen M; Harvey JA; Koh ES; Lim K; Papadatos G; Yap ML; Batumalai V; Lazarus E; Dundas K; Shafiq J; Liney G; Moran C; Metcalfe P; Holloway L
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):905-912. PubMed ID: 27788960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility of Real-Time MR-Navigated Ultrasound with Supine Breast MRI for Suspicious Enhancing Lesions Not Identified on Second-Look Ultrasound.
    Kang DK; Jung Y; Han S; Kim JY; Kim TH
    Ultrasound Med Biol; 2017 Feb; 43(2):412-420. PubMed ID: 27780660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
    Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
    J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
    Salem S; Houseni M; Zidan L; Kandil A
    Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Concordance of MRI and PET/CT Interpretations With Retrospectively Coregistered MRI and PET/CT Data Sets.
    Wang Y; Lim R; Ali Khawaja RD; Blake MA
    Curr Probl Diagn Radiol; 2015; 44(3):232-6. PubMed ID: 25745822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-time-point 18F-FDG PET/CT versus dynamic breast MRI of suspicious breast lesions.
    Imbriaco M; Caprio MG; Limite G; Pace L; De Falco T; Capuano E; Salvatore M
    AJR Am J Roentgenol; 2008 Nov; 191(5):1323-30. PubMed ID: 18941064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved breast cancer detection of prone breast fluorodeoxyglucose-PET in 118 patients.
    Kaida H; Ishibashi M; Fuji T; Kurata S; Uchida M; Baba K; Miyagawa T; Kaibara H; Kawamura S; Ogo E; Hayabuchi N
    Nucl Med Commun; 2008 Oct; 29(10):885-93. PubMed ID: 18769306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerized method for nonrigid MR-to-PET breast-image registration.
    Unlu MZ; Krol A; Magri A; Mandel JA; Lee W; Baum KG; Lipson ED; Coman IL; Feiglin DH
    Comput Biol Med; 2010 Jan; 40(1):37-53. PubMed ID: 19942214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.